G
Giovanni Tripepi
Researcher at National Research Council
Publications - 472
Citations - 19116
Giovanni Tripepi is an academic researcher from National Research Council. The author has contributed to research in topics: Population & Kidney disease. The author has an hindex of 60, co-authored 418 publications receiving 16439 citations. Previous affiliations of Giovanni Tripepi include Tokai University & Karolinska Institutet.
Papers
More filters
Journal ArticleDOI
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study
Carmine Zoccali,Stefanie M. Bode-Böger,Francesca Mallamaci,F. Benedetto,Giovanni Tripepi,Lorenzo Malatino,Alessandro Cataliotti,Ignazio Bellanuova,Isabella Fermo,Jürgen C. Frölich,Rainer H. Böger +10 more
TL;DR: In haemodialysis patients, plasma ADMA is a strong and independent predictor of overall mortality and cardiovascular outcome, and lends support to the hypothesis that accumulation of AD MA is an important risk factor for cardiovascular disease in chronic renal failure.
Journal ArticleDOI
Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal Disease
Carmine Zoccali,Francesca Mallamaci,Giovanni Tripepi,Francesco A. Benedetto,Sebastiano Cutrupi,Saverio Parlongo,Lorenzo Malatino,Graziella Bonanno,Giuseppe Seminara,Francesco Rapisarda,Pasquale Fatuzzo,Michele Buemi,Giacomo Nicocia,Sachiyo Tanaka,Noriyuki Ouchi,Shinji Kihara,Tohru Funahashi,Yuji Matsuzawa +17 more
TL;DR: Plasma ADPN levels are an inverse predictor of cardiovascular outcomes among patients with end-stage renal disease and are related to several metabolic risk factors in a manner consistent with the hypothesis that this protein acts as a protective factor for the cardiovascular system.
Journal ArticleDOI
Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease
Carmine Zoccali,Francesca Mallamaci,Saverio Parlongo,Sebastiano Cutrupi,Francesco A. Benedetto,Giovanni Tripepi,Graziella Bonanno,Francesco Rapisarda,Pasquale Fatuzzo,Giuseppe Seminara,Alessandro Cataliotti,Benedetta Stancanelli,Lorenzo Malatino +12 more
TL;DR: Sympathetic nerve overactivity is associated with mortality and cardiovascular outcomes in ESRD and controlled trials with antiadrenergic drugs are needed to determine whether interference with the sympathetic system could reduce the high cardiovascular morbidity and mortality in dialysis patients.
Journal ArticleDOI
Vitamin D levels and patient outcome in chronic kidney disease.
Pietro Ravani,Fabio Malberti,Giovanni Tripepi,Paola Pecchini,Sebastiano Cutrupi,Patrizia Pizzini,Francesca Mallamaci,Carmine Zoccali +7 more
TL;DR: It is shown that plasma 25-hydroxyvitamin D is an independent inverse predictor of disease progression and death in patients with stage 2-5 chronic kidney disease.
Journal ArticleDOI
Asymmetrical Dimethylarginine Predicts Progression to Dialysis and Death in Patients with Chronic Kidney Disease: A Competing Risks Modeling Approach
Pietro Ravani,Giovanni Tripepi,Fabio Malberti,Sophie Testa,Francesca Mallamaci,Carmine Zoccali +5 more
TL;DR: In patients with mild to advanced chronic kidney disease, plasma ADMA is inversely related to GFR and represents a strong and independent risk marker for progression to ESRD and mortality.